← Every company

Pacira Biosciences Inc SEC Filings

What Pacira Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

PCRX overview →
Filings on file
164
since Nov 2, 2016
Warning signs
1
latest Jun 29, 2017
Last results
Aug 4, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Oct 8, 2026
Material agreement
8-K
Read ↗
Aug 4, 2026
Quarterly report
10-Q
Read ↗
Aug 4, 2026
Results announced
8-K
Read ↗
Jun 30, 2026
Material agreement
8-K
Read ↗
Jun 11, 2026
Executive or director changeShareholder vote
8-K
Read ↗
Apr 30, 2026
Quarterly report
10-Q
Read ↗
Apr 30, 2026
Results announced
8-K
Read ↗
Feb 26, 2026
Annual report
10-K
Read ↗
Feb 26, 2026
Results announced
8-K
Read ↗
Jan 28, 2026
Executive or director change
8-K
Read ↗
Jan 8, 2026
Results announced
8-K
Read ↗
Nov 6, 2025
Quarterly report
10-Q
Read ↗
Nov 6, 2025
Results announced
8-K
Read ↗
Aug 5, 2025
Quarterly report
10-Q
Read ↗
Aug 5, 2025
Results announced
8-K
Read ↗
Jul 10, 2025
Restructuring
8-K
Read ↗
Jul 7, 2025
Material agreementNew debt
8-K
Read ↗
Jun 13, 2025
Executive or director changeShareholder vote
8-K
Read ↗
May 8, 2025
Quarterly report
10-Q
Read ↗
May 8, 2025
Results announced
8-K
Read ↗
Apr 7, 2025
Material agreement
8-K
Read ↗
Feb 27, 2025
Annual report
10-K
Read ↗
Feb 27, 2025
Results announced
8-K
Read ↗
Jan 30, 2025
Executive or director change
8-K
Read ↗
Jan 21, 2025
Executive or director change
8-K
Read ↗
Jan 10, 2025
Results announced
8-K
Read ↗
Nov 6, 2024
Quarterly report
10-Q
Read ↗
Nov 6, 2024
Executive or director changeResults announced
8-K
Read ↗
Oct 21, 2024
Executive or director change
8-K
Read ↗
Sep 27, 2024
Executive or director change
8-K
Read ↗
Jul 30, 2024
Quarterly report
10-Q
Read ↗
Jul 30, 2024
Results announced
8-K
Read ↗
Jun 13, 2024
Executive or director changeShareholder vote
8-K
Read ↗
May 14, 2024
Material agreementNew debtUnregistered share sale
8-K
Read ↗
May 8, 2024
Material agreementNew debt
8-K
Read ↗
May 7, 2024
Quarterly report
10-Q
Read ↗
May 7, 2024
Results announced
8-K
Read ↗
Feb 29, 2024
Annual report
10-K
Read ↗
Feb 29, 2024
Executive or director changeResults announced
8-K
Read ↗
Jan 4, 2024
Results announced
8-K
Read ↗
Dec 21, 2023
Executive or director change
8-K
Read ↗
Nov 2, 2023
Quarterly report
10-Q
Read ↗
Nov 2, 2023
Results announced
8-K
Read ↗
Oct 10, 2023
Executive or director change
8-K
Read ↗
Sep 26, 2023
Executive or director change
8-K
Read ↗
Aug 2, 2023
Quarterly report
10-Q
Read ↗
Aug 2, 2023
Results announced
8-K
Read ↗
Jun 20, 2023
Executive or director changeShareholder vote
8-K
Read ↗
May 3, 2023
Quarterly report
10-Q
Read ↗
May 3, 2023
Results announced
8-K
Read ↗
Apr 3, 2023
Material agreementNew debt
8-K
Read ↗
Mar 22, 2023
Executive or director change
8-K
Read ↗
Feb 28, 2023
Annual report
10-K
Read ↗
Feb 28, 2023
Results announced
8-K
Read ↗
Jan 5, 2023
Results announced
8-K
Read ↗
Dec 13, 2022
Results announced
8-K
Read ↗
Nov 14, 2022
Results announced
8-K
Read ↗
Nov 3, 2022
Quarterly report
10-Q
Read ↗
Nov 3, 2022
Results announced
8-K
Read ↗
Oct 13, 2022
Results announced
8-K
Read ↗
Sep 13, 2022
Results announced
8-K
Read ↗
Aug 10, 2022
Results announced
8-K
Read ↗
Aug 3, 2022
Quarterly report
10-Q
Read ↗
Aug 3, 2022
Results announced
8-K
Read ↗
Jul 14, 2022
Results announced
8-K
Read ↗
Jun 14, 2022
Results announced
8-K
Read ↗
Jun 10, 2022
Executive or director changeShareholder vote
8-K
Read ↗
May 12, 2022
Results announced
8-K
Read ↗
May 4, 2022
Quarterly report
10-Q
Read ↗
May 4, 2022
Executive or director changeResults announced
8-K
Read ↗
Apr 12, 2022
Results announced
8-K
Read ↗
Mar 15, 2022
Results announced
8-K
Read ↗
Feb 28, 2022
Annual report
10-K
Read ↗
Feb 24, 2022
Results announced
8-K
Read ↗
Feb 15, 2022
Results announced
8-K
Read ↗
Jan 6, 2022
Results announced
8-K
Read ↗
Dec 9, 2021
Material agreementNew debt
8-K
Read ↗
Dec 7, 2021
Results announced
8-K
Read ↗
Nov 19, 2021
Acquisition or sale completedMaterial agreement
8-K
Read ↗
Nov 9, 2021
Results announced
8-K
Read ↗
Nov 3, 2021
Quarterly report
10-Q
Read ↗
Nov 3, 2021
Results announced
8-K
Read ↗
Oct 22, 2021
Tender offer
SC TO-T
Read ↗
Oct 12, 2021
Results announcedMaterial agreement
8-K
Read ↗
Sep 15, 2021
Results announced
8-K
Read ↗
Aug 10, 2021
Results announced
8-K
Read ↗
Aug 3, 2021
Quarterly report
10-Q
Read ↗
Aug 3, 2021
Results announced
8-K
Read ↗
Jul 13, 2021
Results announced
8-K
Read ↗
Jun 17, 2021
Executive or director change
8-K
Read ↗
Jun 11, 2021
Executive or director changeShareholder vote
8-K
Read ↗
Jun 8, 2021
Results announced
8-K
Read ↗
May 11, 2021
Results announced
8-K
Read ↗
May 4, 2021
Quarterly report
10-Q
Read ↗
May 4, 2021
Results announced
8-K
Read ↗
Apr 7, 2021
Results announced
8-K
Read ↗
Mar 9, 2021
Results announced
8-K
Read ↗
Mar 1, 2021
Annual report
10-K
Read ↗
Feb 25, 2021
Results announced
8-K
Read ↗
Feb 10, 2021
Results announced
8-K
Read ↗
Jan 7, 2021
Results announced
8-K
Read ↗
Dec 9, 2020
Results announced
8-K
Read ↗
Dec 7, 2020
Executive or director change
8-K
Read ↗
Nov 12, 2020
Results announced
8-K
Read ↗
Oct 30, 2020
Quarterly report
10-Q
Read ↗
Oct 29, 2020
Results announced
8-K
Read ↗
Oct 7, 2020
Results announced
8-K
Read ↗
Sep 9, 2020
Results announced
8-K
Read ↗
Aug 6, 2020
Results announced
8-K/A
Read ↗
Aug 6, 2020
Quarterly report
10-Q
Read ↗
Aug 6, 2020
Results announced
8-K
Read ↗
Jul 10, 2020
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Jul 6, 2020
Results announced
8-K
Read ↗
Jul 2, 2020
Material agreement
8-K
Read ↗
Jun 11, 2020
Executive or director changeShareholder vote
8-K
Read ↗
May 7, 2020
Quarterly report
10-Q
Read ↗
May 7, 2020
Results announced
8-K
Read ↗
Feb 21, 2020
Annual report
10-K
Read ↗
Feb 20, 2020
Results announced
8-K
Read ↗
Jan 10, 2020
Executive or director change
8-K
Read ↗
Jan 9, 2020
Results announced
8-K
Read ↗
Nov 8, 2019
Quarterly report
10-Q
Read ↗
Nov 7, 2019
Results announced
8-K
Read ↗
Sep 19, 2019
Executive or director change
8-K
Read ↗
Aug 8, 2019
Quarterly report
10-Q
Read ↗
Aug 8, 2019
Results announced
8-K
Read ↗
Jun 19, 2019
Executive or director change
8-K
Read ↗
Jun 7, 2019
Executive or director changeShareholder vote
8-K
Read ↗
May 2, 2019
Quarterly report
10-Q
Read ↗
May 2, 2019
Results announced
8-K
Read ↗
Apr 9, 2019
Acquisition or sale completed
8-K
Read ↗
Mar 5, 2019
Material agreement
8-K
Read ↗
Feb 28, 2019
Annual report
10-K
Read ↗
Feb 28, 2019
Results announced
8-K
Read ↗
Jan 3, 2019
Results announced
8-K
Read ↗
Nov 1, 2018
Quarterly report
10-Q
Read ↗
Nov 1, 2018
Results announced
8-K
Read ↗
Aug 2, 2018
Quarterly report
10-Q
Read ↗
Aug 2, 2018
Results announced
8-K
Read ↗
Jul 10, 2018
Results announced
8-K
Read ↗
Jun 15, 2018
Shareholder vote
8-K
Read ↗
May 3, 2018
Quarterly report
10-Q
Read ↗
May 3, 2018
Results announced
8-K
Read ↗
Mar 29, 2018
Executive or director change
8-K
Read ↗
Feb 28, 2018
Annual report
10-K
Read ↗
Feb 28, 2018
Results announced
8-K
Read ↗
Jan 4, 2018
Results announced
8-K
Read ↗
Dec 7, 2017
Executive or director change
8-K
Read ↗
Nov 8, 2017
Quarterly report
10-Q
Read ↗
Nov 8, 2017
Results announced
8-K
Read ↗
Aug 2, 2017
Quarterly report
10-Q
Read ↗
Aug 2, 2017
Results announced
8-K
Read ↗
Jun 29, 2017
Material impairmentRestructuring
8-K
Read ↗
Jun 15, 2017
Executive or director changeShareholder vote
8-K
Read ↗
May 23, 2017
Executive or director change
8-K
Read ↗
May 4, 2017
Quarterly report
10-Q
Read ↗
May 4, 2017
Results announced
8-K
Read ↗
Mar 13, 2017
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Mar 1, 2017
Annual report
10-K
Read ↗
Mar 1, 2017
Results announced
8-K
Read ↗
Jan 25, 2017
Material agreement
8-K
Read ↗
Jan 6, 2017
Results announced
8-K
Read ↗
Nov 2, 2016
Quarterly report
10-Q
Read ↗
Nov 2, 2016
Results announced
8-K
Read ↗

Source: Pacira Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on PCRX

Related datasets